Health Catalyst Inc (NASDAQ: HCAT) on Tuesday, plunged -4.42% from the previous trading day, before settling in for the closing price of $4.53. Within the past 52 weeks, HCAT’s price has moved between $3.76 and $9.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 14.98% annually for the last half of the decade. The company achieved an average annual earnings per share of 5.23%. With a float of $66.95 million, this company’s outstanding shares have now reached $70.21 million.
In an organization with 1500 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 39.22%, operating margin of -19.76%, and the pretax margin is -22.56%.
Health Catalyst Inc (HCAT) Insider Updates
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Health Catalyst Inc is 4.65%, while institutional ownership is 77.20%. The most recent insider transaction that took place on Mar 06 ’25, was worth 62,860. In this transaction General Counsel of this company sold 13,827 shares at a rate of $4.55, taking the stock ownership to the 160,437 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Chief Operating Officer sold 16,902 for $4.52, making the entire transaction worth $76,331. This insider now owns 216,250 shares in total.
Health Catalyst Inc (HCAT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.30% during the next five years compared to 38.24% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Health Catalyst Inc (HCAT) is currently performing well based on its current performance indicators. A quick ratio of 1.42 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit 0.00 in the next quarter and is forecasted to reach 0.43 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.73 million. That was inferior than the volume of 0.84 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 56.25%. Additionally, its Average True Range was 0.30.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 10.40%, which indicates a significant decrease from 44.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.23% in the past 14 days, which was lower than the 63.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.99, while its 200-day Moving Average is $6.81. However, in the short run, Health Catalyst Inc’s stock first resistance to watch stands at $4.54. Second resistance stands at $4.74. The third major resistance level sits at $4.85. If the price goes on to break the first support level at $4.22, it is likely to go to the next support level at $4.11. Assuming the price breaks the second support level, the third support level stands at $3.91.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
Market capitalization of the company is 304.01 million based on 70,211K outstanding shares. Right now, sales total 306,580 K and income totals -69,500 K. The company made 79,610 K in profit during its latest quarter, and -20,670 K in sales during its previous quarter.
